Abivax SA (ABVX)
ABVX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$86.22
-0.83% on the day
Market cap
$7.5B
Mid cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ABVX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | France |
| IPO year | 2023 |
| SEC CIK | 0001956827 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | I0 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-07-02 |
| Latest annual report | 20-F | 2026-03-23 |
| Latest quarterly / interim | 6-K | 2026-09-21 |
Source: SEC EDGAR submissions feed, 105 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.5% |
| 1 month | -18.8% |
| 3 months | -37.1% |
| Year to date | -35.8% |
| 1 year | -9.4% |
| From 52-week high | -40.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SYRE | Spyre Therapeutics Inc. | $80.45 | -6.34% | $7.1B |
| IONS | Ionis Pharmaceuticals Inc. | $42.38 | -2.95% | $7.0B |
| AXSM | Axsome Therapeutics Inc. | $156.32 | -5.83% | $8.2B |
| ARWR | Arrowhead Pharmaceuticals Inc. | $58.13 | -4.28% | $8.2B |
| AMRX | Amneal Pharmaceuticals Inc. | $19.57 | -2.30% | $6.8B |
| TGTX | TG Therapeutics Inc. | $54.34 | -1.68% | $8.3B |
| PRAX | Praxis Precision Medicines Inc. | $243.34 | -3.20% | $6.8B |
| ALKS | Alkermes plc | $39.73 | -1.32% | $6.7B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier